Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +39.28%
#3 Glidr Glidr +36.87%
#4 MowCat MowCat +33.60%
#5 Humanity Humanity +28.11%
#6 Codatta Codatta +19.09%
#7 Walrus Walrus +18.05%
#8 Arowana Arowana +16.50%
#9 Enso Enso +16.29%
#10 Provenance Blockchain Provenance Blockchain +16.03%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Accustem Sciences Inc. Accustem Sciences Inc.

Accustem Sciences Inc.

ACUT
Rank in Stocks #36602
AccuStem Sciences, Inc. operates as a life science firm committed to improving... AccuStem Sciences, Inc. operates as a life science firm committed to improving the outlook for individuals battling cancer. Its primary innovation is the StemPrintER technology, an advanced multi-gene prognostic assay designed to predict the likelihood of recurrence for patients with Endocrine receptor-positive /HER2- breast cancer. The company also offers Spare, a related diagnostic tool that expands upon StemPrintER by incorporating two additional clinical markers. AccuStem Sciences, Inc. is based in New York, New York.
Share Price
$0.156
Last synced: 2026-08-13
Market Cap
$2.51M
Change (1 day)
2.97%
Change (1 year)
-91.28%
Country
US
Trade Accustem Sciences Inc. (ACUT)

Category

Healthcare
Earnings for Accustem Sciences Inc. (ACUT)
Earnings in 2026 TTM: 0
According to Accustem Sciences Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Accustem Sciences Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE